Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by liver disease progression and cardiovascular disease (CVD). The mechanism linking MASLD with CVD is not fully understood. Here, we report experimental and clinical studies suggesting that platelet activation may be implicated in the pathogenesis of MASLD and CVD.
Gut dysbiosis-mediated platelet activation as MASLD and cardiovascular disease link / Violi, Francesco; Pignatelli, Pasquale; Carnevale, Roberto; Bartimoccia, Simona. - In: TRENDS IN ENDOCRINOLOGY AND METABOLISM. - ISSN 1043-2760. - (2026). [10.1016/j.tem.2026.02.003]
Gut dysbiosis-mediated platelet activation as MASLD and cardiovascular disease link
Violi, Francesco
Primo
;Pignatelli, Pasquale
;Carnevale, Roberto;Bartimoccia, SimonaUltimo
2026
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by liver disease progression and cardiovascular disease (CVD). The mechanism linking MASLD with CVD is not fully understood. Here, we report experimental and clinical studies suggesting that platelet activation may be implicated in the pathogenesis of MASLD and CVD.File allegati a questo prodotto
| File | Dimensione | Formato | |
|---|---|---|---|
|
Violi_Gut_2026.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
390.46 kB
Formato
Adobe PDF
|
390.46 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
